4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001695028-26-000008
Chief Financial Officer sold 600 shares at an average $13.50 ($8,103)
- Chief Financial Officer acquired 600 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Piscitelli Dominic Chief Financial Officer | 2026-09-24 | Option exercise 10b5-1 | +600 | $4.36 | $2,616 | 70,428 | D |
| Piscitelli Dominic Chief Financial Officer | 2026-09-24 | Sale 10b5-1 | −100 | $13.50 | $1,350 | 70,328 | D |
| Piscitelli Dominic Chief Financial Officer | 2026-09-24 | Sale 10b5-1 | −500 | $13.51 | $6,753 | 69,828 | D |
| Derivatives | |||||||
| Piscitelli Dominic Chief Financial Officer | 2026-09-24 | Option exercise · Stock Option (right to buy) 10b5-1 | −600 | 91,900 | D | ||
| Open-market sales · 600 sh · avg $13.50 · $8,103 | |||||||
Loading xslF345X06/form4-09252026_110926.xml…